You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

Table 1.  

Clinically Significant Organisms Isolated from Cultures of Blood Samples from 2,009 HIV-infected Outpatients from Thailand, Cambodia, and Vietnam, September 2006–July 2008

Table 2.  

Multivariate Analysis of Risk Factors for Clinically Significant BSI Caused by Mycobacterial or Other Bacterial Infection in HIV-infected Outpatients, Thailand, Cambodia, and Vietnam, September 2006–July 2008*

CME

Bloodstream Infections Among HIV-Infected Outpatients, Southeast Asia

  • Authors: Jay K. Varma, MD; Kimberly D. McCarthy, MS; Theerawit Tasaneeyapan, MSc; Patama Monkongdee, MSc; Michael Kimerling, MD, MPH; Eng Buntheoun, MD; Delphine Sculier, MD, MSc; Chantary Keo; Praphan Phanuphak, MD, PhD; Nipat Teeratakulpisarn, MD; Nibondh Udomsantisuk, MD; Nguyen H. Dung, MD, MS; Nguyen T.N. Lan, MD, PhD; Nguyen T.B. Yen, MD; Kevin P. Cain, MD
  • CME Released: 9/20/2010
  • THIS ACTIVITY HAS EXPIRED FOR CREDIT
  • Valid for credit through: 9/20/2011, 11:59 PM EST
Start Activity


Target Audience and Goal Statement

This activity is intended for primary care clinicians, infectious disease experts, internists, hematologists, public health officials, and other health professionals caring for patients infected with HIV who may be at risk for BSI.

The goal of this activity is to describe prevalence rates of BSI among HIV-infected outpatients in Southeast Asia, as well as factors associated with BSI in this cohort.

Upon completion of this activity, participants will be able to:

  1. Describe overall prevalence of (bloodstream infections) BSIs and prevalence of specific BSIs in HIV-infected outpatients, based on a Southeast Asian study sample
  2. Describe risk factors for overall and specific BSI in HIV-infected persons in that sample


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Author(s)

  • Jay K. Varma, MD

    Thailand Ministry of Public Health – U.S. CDC Collaboration, Nonthaburi, Thailand; U.S. Centers for Disease Control and Prevention, Atlanta, Georgia

    Disclosures

    Disclosure: Jay K. Varma, MD, has disclosed no relevant financial relationships.

  • Kimberly D. McCarthy, MS

    U.S. Centers for Disease Control and Prevention, Atlanta, Georgia

    Disclosures

    Disclosure: Kimberly D. McCarthy, MS, has disclosed no relevant financial relationships.

  • Theerawit Tasaneeyapan, MSc

    Thailand Ministry of Public Health – U.S. CDC Collaboration, Nonthaburi, Thailand

    Disclosures

    Disclosure: Theerawit Tasaneeyapan, MSc, has disclosed no relevant financial relationships.

  • Patama Monkongdee, MSc

    Thailand Ministry of Public Health – U.S. CDC Collaboration, Nonthaburi, Thailand

    Disclosures

    Disclosure: Patama Monkongdee, MSc, has disclosed no relevant financial relationships.

  • Michael Kimerling, MD, MPH

    Bill and Melinda Gates Foundation, Seattle, Washington

    Disclosures

    Disclosure: Michael Kimerling, MD, MPH, has disclosed no relevant financial relationships.

  • Eng Buntheoun, MD

    U.S. Centers for Disease Control and Prevention, Phnom Penh, Cambodia

    Disclosures

    Disclosure: Eng Buntheoun, MD, has disclosed no relevant financial relationships.

  • Delphine Sculier, MD, MSc

    Sihanouk Hospital Center of Hope, Phnom Penh, Cambodia; Institute of Tropical Medicine, Antwerp, Belgium

    Disclosures

    Disclosure: Delphine Sculier, MD, MSc, has disclosed no relevant financial relationships.

  • Chantary Keo

    Institute Pasteur Cambodia, Phnom Penh, Cambodia

    Disclosures

    Disclosure: Chantary Keo has disclosed no relevant financial relationships.

  • Praphan Phanuphak, MD, PhD

    Thai Red Cross AIDS Research Center, Bangkok, Thailand

    Disclosures

    Disclosure: Praphan Phanuphak, MD, PhD, has disclosed no relevant financial relationships.

  • Nipat Teeratakulpisarn, MD

    Thai Red Cross AIDS Research Center, Bangkok, Thailand

    Disclosures

    Disclosure: Nipat Teeratakulpisarn, MD, has disclosed no relevant financial relationships.

  • Nibondh Udomsantisuk, MD

    Chulalongkorn University, Bangkok, Thailand

    Disclosures

    Disclosure: Nibondh Udomsantisuk, MD, has disclosed no relevant financial relationships.

  • Nguyen H. Dung, MD, MS

    Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases, Ho Chi Minh City, Vietnam

    Disclosures

    Disclosure: Nguyen H. Dung, MD, MS, has disclosed no relevant financial relationships.

  • Nguyen T.N. Lan, MD, PhD

    Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases, Ho Chi Minh City, Vietnam

    Disclosures

    Disclosure: Nguyen T.N. Lan, MD, PhD, has disclosed no relevant financial relationships.

  • Nguyen T.B. Yen, MD

    Pham Ngoc Thach Hospital for Tuberculosis and Lung Diseases, Ho Chi Minh City, Vietnam

    Disclosures

    Disclosure: Nguyen T.B. Yen, MD, has disclosed no relevant financial relationships.

  • Kevin P. Cain, MD

    U.S. Centers for Disease Control and Prevention, Atlanta, Georgia

    Disclosures

    Disclosure: Kevin P. Cain, MD, has disclosed no relevant financial relationships.

Editor(s)

  • Karen L. Foster, MA

    Technical Writer/Editor, Emerging Infectious Diseases

    Disclosures

    Disclosure: Karen L. Foster, MA, has disclosed no relevant financial relationships.

CME Author(s)

  • Laurie Barclay, MD

    Freelance writer and reviewer, Medscape, LLC

    Disclosures

    Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.

CME Reviewer(s)

  • Sarah Fleischman

    CME Program Manager, Medscape, LLC

    Disclosures

    Disclosure: Sarah Fleischman has disclosed no relevant financial relationships.

  • Laurie E. Scudder, DNP, NP

    CME Accreditation Coordinator, Medscape, LLC

    Disclosures

    Disclosure: Laurie E. Scudder, DNP, NP, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians.

    Medscape, LLC designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

    Medscape, LLC staff have disclosed that they have no relevant financial relationships.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. MedscapeCME encourages you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CME

Bloodstream Infections Among HIV-Infected Outpatients, Southeast Asia

Authors: Jay K. Varma, MD; Kimberly D. McCarthy, MS; Theerawit Tasaneeyapan, MSc; Patama Monkongdee, MSc; Michael Kimerling, MD, MPH; Eng Buntheoun, MD; Delphine Sculier, MD, MSc; Chantary Keo; Praphan Phanuphak, MD, PhD; Nipat Teeratakulpisarn, MD; Nibondh Udomsantisuk, MD; Nguyen H. Dung, MD, MS; Nguyen T.N. Lan, MD, PhD; Nguyen T.B. Yen, MD; Kevin P. Cain, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 9/20/2010

Valid for credit through: 9/20/2011, 11:59 PM EST

processing....

Abstract and Introduction

Abstract

Bloodstream infections (BSIs) are a major cause of illness in HIV-infected persons. To evaluate prevalence of and risk factors for BSIs in 2,009 HIV-infected outpatients in Cambodia, Thailand, and Vietnam, we performed a single Myco/F Lytic blood culture. Fifty-eight (2.9%) had a clinically significant BSI (i.e., a blood culture positive for an organism known to be a pathogen). Mycobacterium tuberculosis accounted for 31 (54%) of all BSIs, followed by fungi (13 [22%]) and bacteria (9 [16%]). Of patients for whom data were recorded about antiretroviral therapy, 0 of 119 who had received antiretroviral therapy for ≥14 days had a BSI, compared with 3% of 1,801 patients who had not. In multivariate analysis, factors consistently associated with BSI were fever, low CD4+ T-lymphocyte count, abnormalities on chest radiograph, and signs or symptoms of abdominal illness. For HIV-infected outpatients with these risk factors, clinicians should place their highest priority on diagnosing tuberculosis.

Introduction

Bloodstream infections (BSIs) are a major cause of illness in HIV-infected persons. A series of studies, most of which were conducted in sub-Saharan Africa during the 1990s, demonstrated a high prevalence of BSIs (ranging from 10% to 63%) among hospitalized HIV-infected persons who had fever.[1-17] In studies that measured clinical outcomes, the in-hospital death rate for patients with a BSI was high (19%-47%). A variety of pathogens cause BSIs in febrile, hospitalized persons with HIV, most notably non-Typhi Salmonella spp. (6%—15%) and Mycobacterium tuberculosis (2%—19%). BSI with M. tuberculosis appears to be particularly lethal, causing death during hospitalization in up to 47% of patients.[9] Although untreated BSIs are believed to lead rapidly to severe illness, sepsis, and death, patients with BSIs may be able to be identified before they are ill enough to require hospitalization, potentially improving clinical outcomes. Despite the large number of studies that have evaluated BSIs in HIV-infected persons, all previous studies have focused on patients seeking care at hospitals because of fever and did not evaluate infections among outpatients with or without fever.

Although overall transmission rates have declined and antiretroviral therapy (ART) has become more widely available, HIV infection remains a major public health problem in Southeast Asia.[18] Previous studies of BSI in Southeast Asia enrolled only inpatients, and only 1 evaluated a predominantly HIV-infected population.[1,19-21] In this study, we prospectively enrolled patients from multiple HIV testing and treatment clinics in Cambodia, Thailand, and Vietnam to assess BSI prevalence, etiology, and risk factors in outpatients with HIV.

Table of Contents

  1. Abstract and Introduction
  2. Methods
  3. Results
  4. Discussion